Username
Password
Forget Password?
  1. Indices
  2. Commodities
  3. Currencies
Straits Times 3,513.23 -15.69 -0.44%
Hang Seng 30,588.04 -172.37 -0.56%
Dow Jones 24,713.98 -54.95 -0.22%
Shanghai Composite 3,141.30 -13.35 -0.42%
Tianjin ZX USD 
MAINBOARD > MANUFACTURING-2 (T14.SG)   
Chairman: Li Li Qun
 US$1.250 +0.010  +0.99% Buy: 1.250 52-Wk Chg: +0.450  +56.25%
Vol: 1,731 Sell: 1.270 1-Mth Chg: +0.295  +30.89%
25-05-18 17:46:34
Open :-- No. of Shares :768.873m PE :13.4
High :1.290 Market Cap :S$1,288.844m EPS :RMB0.6192
Low :1.250 52-Wk High :1.290 Last 12m Div :RMB0.150000
Last Close :1.290 52-Wk Low :0.840 Yield :1.8
Price-to-Book :1.37 Avg. Vol :954 BVS :S$1.220600
Business
Mfg of Chinese & Western pharmaceutical pdts in China.


Ann'd date for 1Q18 : 10-AUG-17

cd RMB0.107 (2H18) wef 17-05-18 (ex 26-07-18)
Related News (* - headlines only)
3 Counters to Buy with the End of China’s One-Child Policy
Shares Investment - 2015-11-06
BRIEF-Tianjin Pharmaceutical Singapore bought more S-shares of Tianjin Zhongxin
Reuters - 2014-12-12
BRIEF-Zhongxin Pharma says Singapore-based investment firm increased stakes in the company
Reuters - 2014-12-02
Stocks In Focus SG (Boustead Singapore, China MinZhong Food Corp, DBS Group) – 31/10/14
Shares Investment - 2014-10-31
Investors’ Corner (Keppel Corp, Mapletree Greater China Commercial Trust, Tianjin Zhong Xin Pharmaceutical Group, ISOTeam)
Shares Investment - 2014-07-10
Singapore Daily Bulletin – 01/04/13
Shares Investment - 2013-04-01
Singapore Daily Bulletin – 02/04/12
Shares Investment - 2012-04-02
Tianjin Zhongxin Pharmaceutical Group Flag-like At 52-week High
Shares Investment - 2010-11-01
Tianjin Zhong Xin Outperforms Peers
Shares Investment - 2009-05-29
Editorial Desk
Shares Investment - 2009-05-29


« Thomson Medical TIH »

ADVERTISEMENT


Join the tens of thousands of investors reading Shares Investment[+]


Twitter

Facebook

RSS

E-mail

Magazine

ADVERTISEMENT
All Rights Reserved. Pioneers & Leaders (Publishers) Pte Ltd. Best viewed with Mozilla Firefox 3.5 and above.